Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLARITHROMYCIN Cause Intentional product use issue? 21 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Intentional product use issue have been filed in association with CLARITHROMYCIN (Clarithromycin). This represents 0.1% of all adverse event reports for CLARITHROMYCIN.

21
Reports of Intentional product use issue with CLARITHROMYCIN
0.1%
of all CLARITHROMYCIN reports
6
Deaths
16
Hospitalizations

How Dangerous Is Intentional product use issue From CLARITHROMYCIN?

Of the 21 reports, 6 (28.6%) resulted in death, 16 (76.2%) required hospitalization, and 7 (33.3%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLARITHROMYCIN. However, 21 reports have been filed with the FAERS database.

What Other Side Effects Does CLARITHROMYCIN Cause?

Drug ineffective (2,012) Nausea (1,597) Drug hypersensitivity (1,558) Drug interaction (1,288) Diarrhoea (1,228) Dyspnoea (1,151) Malaise (1,131) Headache (1,047) Off label use (944) Vomiting (921)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which CLARITHROMYCIN Alternatives Have Lower Intentional product use issue Risk?

CLARITHROMYCIN vs CLARITIN CLARITHROMYCIN vs CLARITIN CHEWABLE CLARITHROMYCIN vs CLARITIN-D-12 CLARITHROMYCIN vs CLARITIN-D-24 CLARITHROMYCIN vs CLARITIN REDITABS

Related Pages

CLARITHROMYCIN Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue CLARITHROMYCIN Demographics